These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35788704)

  • 1. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
    Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image quality and lesion detectability in low-dose pediatric
    Zhao YM; Li YH; Chen T; Zhang WG; Wang LH; Feng J; Li C; Zhang X; Fan W; Hu YY
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of acquisitions using total-body PET/CT with a half-dose [
    Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
    Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The image quality, lesion detectability, and acquisition time of
    Zhang YQ; Hu PC; Wu RZ; Gu YS; Chen SG; Yu HJ; Wang XQ; Song J; Shi HC
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2507-2515. PubMed ID: 32424483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
    Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
    AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
    [No Abstract]   [Full Text] [Related]  

  • 7. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
    Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
    Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
    Tan H; Cai D; Sui X; Qi C; Mao W; Zhang Y; Liu G; Yu H; Chen S; Hu P; Gu J; Shi H
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1002-1011. PubMed ID: 34462790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [
    Mingels C; Spencer BA; Nalbant H; Omidvari N; Rokni M; Rominger A; Sen F; Cherry SR; Badawi RD; Abdelhafez YG; Nardo L
    J Nucl Med; 2024 Jul; 65(7):1101-1106. PubMed ID: 38664017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total-body
    Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [
    Alberts I; Sachpekidis C; Prenosil G; Viscione M; Bohn KP; Mingels C; Shi K; Ashar-Oromieh A; Rominger A
    Ann Nucl Med; 2021 Apr; 35(4):485-492. PubMed ID: 33550515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the long axial field-of-view PET/CT with low-dose [
    Sachpekidis C; Pan L; Kopp-Schneider A; Weru V; Hassel JC; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1158-1167. PubMed ID: 36474125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head intra-individual comparison of total-body 2-[
    Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
    Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of short acquisition time using
    Li M; Cui X; Yue H; Ma C; Li K; Chai L; Ge M; Li H; Ng YL; Zhou Y; Shi J; Duan Y; Cheng Z
    EJNMMI Res; 2024 Feb; 14(1):21. PubMed ID: 38409511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced count pediatric whole-body
    Alves VPV; Ata NA; MacLean J; Sharp SE; Li Y; Brady S; Trout AT
    Pediatr Radiol; 2024 Jan; 54(1):170-180. PubMed ID: 37962603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image Quality and Activity Optimization in Oncologic
    van Sluis J; Boellaard R; Dierckx RAJO; Stormezand GN; Glaudemans AWJM; Noordzij W
    J Nucl Med; 2020 May; 61(5):764-771. PubMed ID: 31628214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low
    Hu Y; Liu G; Yu H; Wang Y; Li C; Tan H; Chen S; Gu J; Shi H
    J Nucl Med; 2022 Jun; 63(6):959-965. PubMed ID: 34593593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploration of the feasibility and clinical value of half-dose 5-h total-body
    Adili D; Cai D; Wu B; Yu H; Gu Y; Zhang Y; Shi H
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2375-2385. PubMed ID: 36864361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
    Schoen M; Braun T; Manava P; Ludwigs S; Lell M
    Nuklearmedizin; 2018 Apr; 57(2):50-55. PubMed ID: 29590675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.